The role of the toll-like receptor TLR4 in hepatitis B virus-associated glomerulonephritis

Archives of Virology

Volumn 158, Issue 2, 2013, Pages 425-433

  Zhou, Yi ^a   Zhu, Nan ^a   Wang, Xuan ^a   Wang, Ling ^a   Gu, Li jie ^a   Yuan, Wei jie ^a  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VIRUS;

EID: 84873147166     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-012-1508-3     Document Type: Article

References (14)

1. Arbuthnot P, Kew M (2001) Hepatitis B virus and hepatocellular carcinoma. Int J Exp Pathol 2: 77-100.
2. Lee WM (1997) Hepatitis B virus infection. N Engl J Med 337: 1733-1745.
3. Zhang D, Zhang G, Hayden MS, Greenblatt MB, Bussey C, Flavell RA, Ghosh S (2004) A toll-like receptor that prevents infection by uropathogenic bacteria. Science 303: 1522-1526.
4. Akira S, Takeda K, Kaisho T (2001) Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2: 675-680.
5. Zarember KA, Godowski PJ (2002) Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 168: 554-561.
6. Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, Tripp RA, Walsh EE, Freeman MW, Golenbock DT, Anderson LJ, Barton GM, Medzhitov R (2003) Toll-like receptor signaling pathways. Science 300: 1524-1525.
7. Ghosh S, May MJ, Kopp EB (1998) NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16: 225-260.
8. Combes B, Stastny P, Shorey J et al (1971) Glomerulonephritis with deposition of Australia antigenantibody complexes in glomerular basement membrane. Lancet 2: 234-237.
9. Lai KN, Lai FM, Tam JS et al (1988) Strong association between IgA nephropathy and hepatitis B surface antigenemia in endemic areas. Clin Nephrol 29: 229-234.
10. John B, Crispe IN (2005) TLR-4 regulates CD8+ T cell tra-pping in the liver. J Immunol 175: 1643-1650.
11. Akira S, Takeda K (2004) Toll-like receptor signaling. Nat Rev Immunol 4: 499-511.
12. Chang WW, Su IJ, Lei HY et al (2003) The role of inducible nitric oxide synthasein amurine acute hepatitis B virus(HBV)infection model induced by hydrodynamics-based in vivo transfection of HBV-DNA. J Hepatol 39: 834-842.
13. Jun W, Zhong JM, Min J et al (2009) Hepatitis B Virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells. Hepatology 49: 1132-1140.
14. Lin S, Wu M, Xu Y et al (2007) Inhibition of hepatitis B virus replication by MyD88 is mediated by nuclear factor-kappaB activation. Biochimica et Biophysica Acta 1772: 1150-1157.